Volitionrx Ltd (NYSE: VNRX) — Healthcare · Share Price, Chart & Market Data
About: VolitionRx Limited, a multi-national epigenetics company, develops blood tests to help detect and monitor a range of cancers, and diseases associated with NETosis in the United States, Europe, and Asia. The company offers Nu.Q Vet, a cancer screening test for dogs and other animals; Nu.Q Nets, detects diseases associated with NETosis, such as sepsis; Nu.Q Discover, a solution to profiling nucleosomes; Nu.Q Cancer for predicting treatment response, monitoring treatment response and disease progression, and amending a patient's cancer treatment regimen; and Capture-PCR and Capture-Seq, which are isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection. VolitionRx Limited is based in Henderson, Nevada.
Sector: Healthcare
Industry: Medical Devices
Latest price: $2.64 (-5.04%)
VNRXVolitionrx Ltd
Loading watchlist status…
Trade VNRX now
Volitionrx Ltd share price
VNRX price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 3:14 am GMT+0
VNRX price performance
-8.333%
5D
-30.526%
1M
-51.648%
YTD
-74.118%
1Y
VNRX price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NYSE rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 3:14 am GMT+0
VNRX details
VNRX Market Signals